Advisory Boards

The Impact Board (IB) consists of a mix of junior and senior members of FORTEe, from academia and industry, as well as patient representatives. The IB designs a structured communication plan for dissemination and the exploitation of the project’s results, monitors the steps being taken and oversees and evaluates the comprehensive internal and external dissemination of the project’s results and knowledge gain (together with the Project Management Office, WP1 and WP6).

The Scientific and Ethical Advisory Board (SEAB) is a consultative body which is formed to ensure and improve the scientific performance and the quality of results of FORTEe. The SEAB advises the General Assembly (GA) and the Project Management Office (PMO) upon request, and provides non-binding advice as decision making support. Members of the SEAB do not have a right to vote, but are cordially invited to attend the annual GA meetings in order to monitor the progress within each work package, assess the scientific quality of the project, and provide critique, feedback and support.

The CTMC coordinates and supervises the clinical trial with the following tasks:

• Setting up and implementing the logistics around the clinical trial
• Providing support to FORTEe members concerning the clinical trial
• Reviewing and assessing the results of the clinical trial and monitoring whether any changes to the study protocol are necessary

The Data and Safety Monitoring Committee (DSMC) will ensure data accuracy, data privacy, and data security within FORTEe and comprises the trial statistician and experts in data and study management. The DSMC will review any issues concerning the privacy and secure handling of the data of the trial participants as well as the integrity of the data.